Back to all studies
CompletedNCT00119652

Safety study of efficacy & Safety of Quetiapine Fumarate & Paroxetine in depression in bipolarity

This study is completed in the United States, in Australia, in Chile, .... It is testing efficacy & Safety of Quetiapine Fumarate & Paroxetine for depression in bipolarity.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

This summary needs review. Please check the official study record and contact the research team for details.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateMay 2005
Recruitment status
Completed
Enrollment listed in the registry
676
Sponsor
AstraZeneca
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Psychotherapy / behavioral intervention, Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Australia, Chile, ...
Age range
From 18 Years to 65 Years
Official registry ID
NCT00119652
Official title
Multicentre, Double-blind, Randomised, Parallel Group, Placebo Controlled, Phase 3 Study of the Efficacy & Safety of Quetiapine Fumarate & Paroxetine as Monotherapy in Adult Patients With Bipolar Depression for 8 Weeks & Quetiapine in Continuation (Abbreviated)

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT00119652. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Australia · 5 sites
  • Research Site
    Brisbane, Queensland
    Site status: Not listed — confirm with the team
  • Research Site
    Everton Park, Queensland
    Site status: Not listed — confirm with the team
  • Research Site
    Southport, Queensland
    Site status: Not listed — confirm with the team
  • Research Site
    Epping, Victoria
    Site status: Not listed — confirm with the team
  • Research Site
    Malvern, Victoria
    Site status: Not listed — confirm with the team
Chile · 2 sites
  • Research Site
    Providencia Santiago
    Site status: Not listed — confirm with the team
  • Research Site
    Santiago
    Site status: Not listed — confirm with the team
Colombia · 1 site
  • Research Site
    Bogotá
    Site status: Not listed — confirm with the team
Costa Rica · 1 site
  • Research Site
    San José
    Site status: Not listed — confirm with the team
Greece · 3 sites
  • Research Site
    Athens
    Site status: Not listed — confirm with the team
  • Research Site
    Thessaloniki
    Site status: Not listed — confirm with the team
  • Research Site
    Tripoli
    Site status: Not listed — confirm with the team
Mexico · 2 sites
  • Research Site
    México
    Site status: Not listed — confirm with the team
  • Research Site
    Yucatán
    Site status: Not listed — confirm with the team
Peru · 2 sites
  • Research Site
    Lima
    Site status: Not listed — confirm with the team
  • Research Site
    San Borja
    Site status: Not listed — confirm with the team
Romania · 4 sites
  • Research Site
    Bucharest
    Site status: Not listed — confirm with the team
  • Research Site
    Galati
    Site status: Not listed — confirm with the team
  • Research Site
    Iași
    Site status: Not listed — confirm with the team
  • Research Site
    Măgura
    Site status: Not listed — confirm with the team
South Africa · 4 sites
  • Research Site
    Benoni
    Site status: Not listed — confirm with the team
  • Research Site
    Cape Town
    Site status: Not listed — confirm with the team
  • Research Site
    Durban
    Site status: Not listed — confirm with the team
  • Research Site
    Pretoria
    Site status: Not listed — confirm with the team
Türkiye · 3 sites
  • Research Site
    Gaziantep
    Site status: Not listed — confirm with the team
  • Research Site
    Istanbul
    Site status: Not listed — confirm with the team
  • Research Site
    Manisa
    Site status: Not listed — confirm with the team
United States · 28 sites
  • Research Site
    Phoenix, Arizona
    Site status: Not listed — confirm with the team
  • Research Site
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Research Site
    National City, California
    Site status: Not listed — confirm with the team
  • Research Site
    San Clemente, California
    Site status: Not listed — confirm with the team
  • Research Site
    San Diego, California
    Site status: Not listed — confirm with the team
  • Research Site
    Maitland, Florida
    Site status: Not listed — confirm with the team
  • Research Site
    Winter Park, Florida
    Site status: Not listed — confirm with the team
  • Research Site
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Research Site
    Smyrna, Georgia
    Site status: Not listed — confirm with the team
  • Research Site
    Northfield, Illinois
    Site status: Not listed — confirm with the team
  • Research Site
    Oak Brook, Illinois
    Site status: Not listed — confirm with the team
  • Research Site
    New Orleans, Louisiana
    Site status: Not listed — confirm with the team
  • Research Site
    Shreveport, Louisiana
    Site status: Not listed — confirm with the team
  • Research Site
    Glen Burnie, Maryland
    Site status: Not listed — confirm with the team
  • Research Site
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • Research Site
    Clementon, New Jersey
    Site status: Not listed — confirm with the team
  • Research Site
    New York, New York
    Site status: Not listed — confirm with the team
  • Research Site
    Raleigh, North Carolina
    Site status: Not listed — confirm with the team
  • Research Site
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • Research Site
    Dayton, Ohio
    Site status: Not listed — confirm with the team
  • Research Site
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Research Site
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Research Site
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Research Site
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Research Site
    Irving, Texas
    Site status: Not listed — confirm with the team
  • Research Site
    Richmond, Virginia
    Site status: Not listed — confirm with the team
  • Research Site
    Bellevue, Washington
    Site status: Not listed — confirm with the team
  • Research Site
    Kirkland, Washington
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving quetiapine fumarate (Seroquel), paroxetine, mood stabilizing activity. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with bipolarity; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by AstraZeneca, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me